Novavax (NVAX) Tops Q2 EPS by 1c

Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $14 million versus the consensus estimate of $9.9 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance